Applications: |
Immunodepletion/Immunocompetition |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
CRMP1 Blocking Peptide for STJ500611 is synthetically produced from the 80-130 sequence and is suitable for use in western blot applications. |
Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Immunogen Region: |
80-130 |
Specificity: |
This blocking peptide is recommended for use in combination with CRMP1 antibody, STJ500611 |
Immunogen: |
Synthetic peptide corresponding to 80-130 on CRMP1 protein. |
Background | Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance